BICYCLERD LIMITED
Get an alert when BICYCLERD LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-26 (in 2mo)
Last made up 2025-07-12
Watchouts
None on the register
Cash
£466K
Latest balance sheet
Net assets
-£3M
Equity attributable
Employees
0
Average over period
Profit before tax
-£169K
Period ending 2024-12-31
Name history
Renamed 1 time since incorporation
- BICYCLERD LIMITED 2017-10-27 → present
- BICYCLE THERAPEUTICS LIMITED 2009-07-13 → 2017-10-27
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£341,000 | -£694,000 | |
| Profit before tax | -£366,000 | -£169,000 | |
| Net profit | -£365,000 | -£170,000 | |
| Cash | £652,000 | £466,000 | |
| Total assets less current liabilities | -£2,855,000 | -£3,025,000 | |
| Net assets | -£2,855,000 | -£3,025,000 | |
| Equity | -£2,855,000 | -£3,025,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 11.9% | 22.9% | |
| Current ratio | 0.60x | 0.55x | |
| Interest cover | -13.12x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company's parent, Bicycle Therapeutics plc, has confirmed that it will provide financial support to the Company such that the Company is able to operate as a going concern and to settle its liabilities as they fall due. This financial support will include: Not seeking the repayment of amounts advanced to the Company by the Parent and/or other members of the Parent group unless adequate alternative financing has been secured by the Company; and Advancing further amounts to the Company as required by the Company.”
Significant events
- “On 9 July 2024, the parent company repaid in its entirety and voluntarily terminated the loan and security agreement with Hercules Capital, Inc.”
- “In December 2024, the Company, CRTL and Cancer Research UK entered into an agreement pursuant to which all rights and obligations under the original agreement with Cancer Research UK expired and terminated. The Company recognised a gain on the derecognition of the financial liability of £525k during the year ended 31 December 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEE, Kevin | Director | 2015-09-02 | Apr 1968 | English |
| QADIR, Mirza Zafar Iskander | Director | 2021-06-17 | Aug 1983 | British |
| SKYNNER, Michael | Director | 2021-06-17 | Jan 1969 | British |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MUNCEY, Andrew | Secretary | 2015-10-01 | 2017-12-31 |
| BR SECRETARIES LTD | Corporate Secretary | 2009-07-13 | 2012-07-25 |
| M & R SECRETARIAL SERVICES LIMITED | Corporate Secretary | 2012-07-25 | 2017-12-30 |
| ANSTEY, Michael Leith, Dr | Director | 2017-05-26 | 2020-06-30 |
| BINGHAM, Catherine Elizabeth, Dame | Director | 2009-12-07 | 2021-06-17 |
| BOOTH, Bruce Lee | Director | 2011-01-01 | 2015-01-22 |
| BOURQUE, Janice | Director | 2019-08-12 | 2021-06-17 |
| GUENTHER, Rolf, Dr | Director | 2012-04-01 | 2015-06-10 |
| HARLAND, Deborah, Dr | Director | 2009-12-07 | 2019-09-27 |
| HAU, Bosun | Director | 2019-05-22 | 2020-06-30 |
| HODITS, Regina, Dr | Director | 2009-07-13 | 2011-01-01 |
| HOFFMAN, Stephen | Director | 2016-05-01 | 2019-03-19 |
| JORDAN, Veronica Geraldeen Huber, Ms. | Director | 2019-10-30 | 2021-06-17 |
| KENDER, Richard | Director | 2019-08-12 | 2021-06-17 |
| KOENIG, Anja, Dr | Director | 2009-07-21 | 2019-05-22 |
| KRISHNAN, Viswanathan, Mr. | Director | 2018-12-22 | 2019-05-22 |
| LEE, James | Director | 2017-07-11 | 2018-07-12 |
| LEGAULT, Pierre | Director | 2019-03-19 | 2021-06-17 |
| NG, Carolyn, Dr | Director | 2018-07-12 | 2020-06-30 |
| RHODES, Jason Paul | Director | 2015-01-22 | 2019-05-22 |
| SANDHAM, Andrew Peter | Director | 2011-01-01 | 2016-05-19 |
| SHEN, Christopher | Director | 2017-05-26 | 2017-07-11 |
| TAPOLCZAY, David Joszef | Director | 2009-07-21 | 2011-12-05 |
| TITE, John Philip | Director | 2009-07-21 | 2012-04-01 |
| WINTER, Gregory Paul, Sir | Director | 2009-07-21 | 2021-06-17 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bicycle Therapeutics Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-12-04 | Active |
Filing timeline
Last 20 of 179 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-07-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-24 | AA | accounts | Accounts with accounts type full | |
| 2024-08-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-07-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-28 | AA | accounts | Accounts with accounts type full | |
| 2023-08-11 | CH01 | officers | Change person director company with change date | |
| 2023-07-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-23 | AA | accounts | Accounts with accounts type full | |
| 2022-08-09 | CH01 | officers | Change person director company with change date | |
| 2022-07-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-14 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-07-14 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-07-04 | AA | accounts | Accounts with accounts type full | |
| 2022-06-28 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-06-28 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2021-07-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-07-12 | CH01 | officers | Change person director company with change date | |
| 2021-07-10 | AA | accounts | Accounts with accounts type full | |
| 2021-06-21 | TM01 | officers | Termination director company with name termination date | |
| 2021-06-18 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31